Literature DB >> 658619

Aldosterone responsiveness in patients with diabetes mellitus.

A R Christlieb, A Kaldany, J A D'Elia, G H Williams.   

Abstract

Plasma aldosterone (PA) and plasma renin activity (PRA) were determined in 44 diabetics, of whom nine were normotensive but not nephropathic (group 1), 10 were hypertensive but not nephropathic (group 2), and 25 were hypertensive and nephropathic (group 3); they were kept in balance on a diet composed of 10 to 20 mEq. of sodium (Na) and 100 mEq. of potassium (K). Supine PA in group 1 was 38 +/- 7 ng. per deciliter, whereas in normals it was 24 +/- 2 ng. per deciliter (P less than 0.05); beyond that, neither supine nor upright PA or PRA differed significantly from normal in groups 1 and 2. By contrast, in group 3, supine PA was 13 +/- 1 ng. per deciliter and PRA 2.0 +/- 0.2 ng./ml. and upright PA was 39 +/- 7 ng. per deciliter and PRA 3.8 +/- 0.5 ng./ml., all significantly lower than those in the other groups (P less than 0.01). Nine patients, one in group 1 and eight in group 3, had low supine and upright PA and PRA; four had hyperkalemia. An additional nine patients in group 3 had low upright PA, with normal or low PRA; two had hyperkalemia. Of the 18 patients with low upright PA, K correlated with glucose (R = 0.46, P less than 0.05). These results suggest (1) the renin-aldosterone system generally responds normally in diabetics without nephropathy but responds subnormally when nephropathy is present, (2) hyporeninemic hypoaldosteronism is frequent in diabetics with nephropathy but may occur in the absence of clinical nephropathy, and (3) hyperkalemia in some diabetic patients may be secondary to hypoaldosteronemia and hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 658619     DOI: 10.2337/diab.27.7.732

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.

Authors:  E Hommel; H H Parving; E Mathiesen; B Edsberg; M Damkjaer Nielsen; J Giese
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

2.  Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.

Authors:  J B Ferriss; P A Sullivan; H Gonggrijp; A A Long; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

3.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

4.  Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy.

Authors:  I K Cheng; J T Ma; G R Yeh; M K Chan
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 5.  [The renin-angiotensin system in diabetic patients].

Authors:  J Mann; E Ritz
Journal:  Klin Wochenschr       Date:  1988-09-15

6.  The activity of the renin-angiotensin-aldosterone system before and during submaximal bicycle exercise in relation to circulatory catecholamines in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Sundkvist; B Bergström; M Bramnert; B Lilja; P Manhem
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

7.  Hyperkalaemia in diabetes: prevalence and associations.

Authors:  P R Jarman; A M Kehely; H M Mather
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

Review 8.  Therapeutic Renin Inhibition in Diabetic Nephropathy-A Review of the Physiological Evidence.

Authors:  Bianca Domingues Massolini; Stephanie San Gregorio Contieri; Giulia Severini Lazarini; Paula Antoun Bellacosa; Mirela Dobre; Georg Petroianu; Andrei Brateanu; Luciana Aparecida Campos; Ovidiu Constantin Baltatu
Journal:  Front Physiol       Date:  2020-03-12       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.